Skip to main content

Together we are beating cancer

Donate now

Michael Walsh

Michael studied biochemistry at the University of Glasgow, before completing a PhD at Queen Mary University of London where he investigated how cells communicate. After that he worked in a science press office and joined Cancer Research UK’s News and Multimedia team in 2016, where he writes for the blog and news feed.
Showing 12 out of 43 results

CRISPR genome editing has received lots of attention and hype, so we took a look at what it really means for the future of cancer research. CRISPR genome editing has received lots of attention and hype, so we took a look at what it really means for the future of cancer research.

by Michael Walsh | Analysis | 12 January 2018

12 January 2018

This entry is part 7 of 11 in the series Radiotherapy

In this week's news a drug was approved for some lung cancer patients in England, and vaping could be a big piece of the quitting smoking puzzle. In this week's news a drug was approved for some lung cancer patients in England, and vaping could be a big piece of the quitting smoking puzzle.

by Michael Walsh | Analysis | 23 September 2017

23 September 2017